KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer

Liao, Wenting, Overman, Michael J., Boutin, Adam T., Shang, Xiaoying, Zhao, Di, Dey, Prasenjit, Li, Jiexi, Wang, Guocan +19 more·2019·Cancer Cell

DOI 10.1016/j.ccell.2019.02.008

Cited by (619)

Items 301–400 of 619

Colorectal cancer: epidemiology, carcinogenesis, molecular subtypes and cellular mechanisms of therapy resistance (analytical review)
P. E. Maksimova, Elena Petrovna Golubinskaya, Сеферов Бекир Джелялович, Evgeniya Yu. Zyablitskaya · 2023 · Koloproktologia
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential
Eric Jou · 2023 · Exploration of Targeted Anti-tumor Therapy
Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses
Yong Liu, Youcheng Liang, Yongjian Su, Jiaqi Hu, Jianbo Sun, Mingbin Zheng, Zunnan Huang · 2023 · Computers in Biology and Medicine
Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment
Jia Xiong, Hui Wang, Qingqing Wang · 2021 · Advanced Biology
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
Hye Eun Park, Seung-Yeon Yoo, Nam‐Yun Cho, Jeong Mo Bae, Sae‐Won Han, Hye Seung Lee, Kyu Joo Park, Tae‐You Kim, Gyeong Hoon Kang · 2021 · Scientific Reports
What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?
Milena Peruhova, Monika Peshevska-Sekulovska, Boris Milev Krastev, Gabriela Georgieva Panayotova, Viktoriya Georgieva, Rossitza Konakchieva, Georgi Nikolaev, Tsvetelina Veselinova Velikova · 2020 · World Journal of Gastroenterology
Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development
Gmeiner, William H · 2021 · OncoTargets and Therapy
Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L)1 therapy: a systematic review
Fan Zhang, Banglu Wang, Menghuan Wu, Liwen Zhang, Mei Qing Ji · 2025 · Frontiers in Immunology
Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer
Sheng-Nan Ren, Zhan-Yi Zhang, Rui-Jie Guo, Daren Wang, Fangfang Chen, Xuebo Chen, Xuedong Fang · 2023 · World Journal of Gastroenterology
A muti-modal feature fusion method based on deep learning for predicting immunotherapy response
Xiong Li, Xuan Feng, Juan Zhou, Yuchao Luo, Xiao Chen, Jiapeng Zhao, Haowen Chen, Guoming Xiong, Guoliang Luo · 2024 · Journal of Theoretical Biology
The Role of Interferon Regulatory Factors in Liver Diseases
Chuanfei Zeng, Xiaoqin Zhu, Huan Li, Ziyin Huang, Mingkai Chen · 2024 · International Journal of Molecular Sciences
KRAS mutations are negatively correlated with immunity in colon cancer
Xiaorui Fu, Xinyi Wang, Jinzhong Duanmu, Taiyuan Li, Qunguang Jiang · 2020 · Aging
HOXA7 promotes the metastasis of KRAS mutant colorectal cancer by regulating myeloid-derived suppressor cells
Yunzhi Dang, Jiao Yu, Shuhong Zhao, Ximing Cao, Qing Wang · 2022 · Cancer Cell International
Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategies
Xinyi Ye, Xizhu Fang, Fangfang Li, Dan Jin · 2025 · Critical Reviews in Oncology/Hematology
Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance
Jiyu Han, Weitian Liang, Kai Li · 2026 · Frontiers in Cell and Developmental Biology
Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance
Yeelon Yeoh, Teck Yew Low, Nadiah Abu, Pey Yee Lee · 2021 · PeerJ
FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer
Junfeng Qiu, Mingzhou Li, Cailin Su, Yihao Liang, Ruizhang Ou, Xiaoning Chen, Chengmei Huang, Yaxin Zhang, Yaping Ye, Wenting Liao et al. · 2022 · Frontiers in Oncology
KRAS inhibition in metastatic colorectal cancer: An update
Maliha Nusrat, Rona D. Yaeger · 2023 · Current Opinion in Pharmacology
LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche
Xianying Li, Shuhang Liang, Mingming Fei, Kun Ma, Linmao Sun, Yao Liu, Lianxin Liu, Jiabei Wang · 2024 · International Journal of Biological Sciences
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan C. Augustin, Luigi Barrea, Davide Bedognetti, Tullia Carmela Bruno, Alberto Carturan, Christian Hammer, Winson S. Ho, Jakob Nikolas Kather, Tomas Kirchhoff et al. · 2025 · Journal for ImmunoTherapy of Cancer
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
Shuling Han, Luying Cui, Bojun Wang, Yuli Ruan, Mengde Shi, Chang Sook Hong, Xin Guan, Zhuo Chen, Yingjue Li, Yuanyu Liao et al. · 2025 · Cancer Immunology Research
Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment
Jiayao Ma, Shenao Fu, Jun Tan, Ying Han, Yihong Chen, Xiangying Deng, Hong Shen, Shan Zeng, Yinghui Peng, Changjing Cai · 2025 · Advanced Science
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma
Larissa Anastácio da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S. Phadke, Michael F. Emmons, Ximo Pechuan-Jorge, Felix Mbuga, Oscar E. Ospina, Christopher Chow, Lillian Seu, Olivia L. Rose et al. · 2025 · Cancer Immunology Research
Conquering oncogenic KRAS and its bypass mechanisms
Pingping Hou, Yanru Wang · 2022 · Theranostics
A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
Dong Hou, Jia-nan Tan, Shengning Zhou, Yang Xu, Zhihong Zhang, Guangyu Zhong, Lin Zhong, Bin Yang, Fanghai Han · 2022 · Frontiers in Genetics
Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice
Qing Kong, Huahe Zhu, Weiyi Gong, Xiaohong Deng, Baojun Liu, Jingcheng Dong · 2023 · Journal of Ethnopharmacology
An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer
Ateş Kutay Tenekeci, Ahmet Arda Unal, Furkan Ceylan, Mehmet Ali Nahit Sendur · 2024 · Future Oncology
Immune-associated biomarkers for early diagnosis of Parkinson’s disease based on hematological lncRNA–mRNA co-expression
Kecheng Lei, Liwen Zhang, Yijing He, Hui Sun, Weifang Tong, Yichun Xu, Lingjing Jin · 2020 · Bioscience Reports
Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer
Yuan‐Yao Tsai, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Shu‐Fen Chiang, Yusen Eason Lin, Tao-Wei Ke, Chi-Hsien Huang, Te-Hung Chen, Yiwen Jiang et al. · 2025 · Cancer Letters
Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms
Sihan Chen, Guodong Cao, Wei Wu, Yida Lu, Xiaobo He, Yang Lei, Ke Chen, Bo Chen, Maoming Xiong · 2020 · World Journal of Surgical Oncology
Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives
Guanglin Cui · 2022 · Biomedicine & Pharmacotherapy
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
Barbara Seliger, Chiara Massa · 2022 · Frontiers in Immunology
Co-dependencies in the tumor immune microenvironment
Peiwen Chen, Prasenjit Dey · 2022 · Oncogene
HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells
Jiao Yu, Xiaojiao Chen, Shuhong Zhao, Jingchen Jing, Qing Wang, Yunzhi Dang · 2022 · Journal of Cancer
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
Xuefeng Fang, Chenhan Zhong, Shanshan Weng, Hanguang Hu, Jian Wang, Qian Xiao, Jianwei Wang, Lifeng Sun, Dong Xu, Xiujun Liao et al. · 2023 · BMC Cancer
Glutamic-pyruvic transaminase 1 deficiency–mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression
Li Xiong, Xin Yang, Huashan Liu, Xianrui Wu, Tanxing Cai, Ming Yuan, Liang Huang, Chi Zhou, Xiaobin Zheng, Wenxin Li et al. · 2025 · Science Translational Medicine
Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis
Imran Khan, Catherine B. MarElia, Julia E. Lefler, Mariyam Zuberi, Eric Denbaum, Akiko Koide, Dean M. Connor, Ann‐Marie Broome, Thierry Pécot, Cynthia Dawn Timmers et al. · 2021 · Small GTPases
Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses
Qiyuan Lv, Haizhou Zou, Yuyan Xu, Zhenyong Shao, Ruoqi Wu, Kejie Li, Xia Deng, Dian-na Gu, Hong-xiao Jiang, Meng Su et al. · 2021 · Bioengineered
Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment
Iman Mamdouh Talaat, Noha Mousaad Elemam, Shroque Zaher, Maha Mohamed Saber-Ayad · 2022 · Frontiers in Medicine
GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells
Yannick Sebastiaan Rakké, Lucia Campos Carrascosa, Adriaan A. van Beek, Valeska de Ruiter, Rachelle S. van Gemerden, Michail Doukas, Pascal Gabriël Doornebosch, Maarten Vermaas, Susan ter Borg, Erwin van der Harst et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
Extracellular CD44 lactylation impairs CD8+ T cell function in KRAS-mutant colorectal cancer
Yun Yang, Yong Wu, Xin Guo, Wen-Juan Gan, Wen-Xin Wu, Wei-Yi Shi, Xiaoshun He, Yi-Xuan Liu, Shan Wan, Zhi Jiang et al. · 2026 · Nature Metabolism
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Hang Ruan, Brian J. Leibowitz, Yingpeng Peng, Lin Shen, Lujia Chen, Charlie Kuang, Robert E. Schoen, Xinghua Lu, Lin Zhang, Jian Yu · 2022 · Molecular Biomedicine
Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy
Cheng Ye, Chunlu Dong, Yanyan Lin, Huaqing Shi, Wence Zhou · 2023 · Microorganisms
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine
İbrahim Halil Şahin, Turçin Saridogan, Rüveyda Ayasun, Masood Pasha Syed, Vikram C. Gorantla, Monica Khunger Malhotra, Roby Antony Thomas, John C. Rhee, Janie Yue Zhang, Dennis J. Hsu et al. · 2024 · JCO Oncology Practice
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment
Hideyuki Masui, Kenji Kawada, Yoshiro Itatani, Hideyo Hirai, Yuki Nakanishi, Yoshiyuki Kiyasu, Keita Hanada, Michio T. OKAMOTO, Wataru Hirata, Yasuyo Nishikawa et al. · 2024 · British Journal of Cancer
Optimizing hybrid ensemble feature selection strategies for transcriptomic biomarker discovery in complex diseases
Elsa Claude, Mickaël Leclercq, Patricia Thébault, Arnaud Droit, Raluca Uricaru · 2024 · NAR Genomics and Bioinformatics
Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20
Ji Ae Lee, Mi-Kyoung Seo, Seungyeon Yoo, Nam‐Yun Cho, Yoonjin Kwak, Kyoungbun Lee, Jung Ho Kim, Gyeong Hoon Kang · 2022 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
Yunchang Li, Lanlin Hu, Xinhao Peng, Huasheng Xu, Bo Tang, Chuan Shan Xu · 2022 · Cancer Drug Resistance
Targeting KRAS : Crossroads of Signaling and Immune Inhibition
Shumei Kato, Yu Fujiwara, David S. Hong · 2022 · Journal of Immunotherapy and Precision Oncology
Evaluation of immunotherapy efficacy in gynecologic cancer
Genyi Jiang, Qianhua Wu, Bilan Li · 2023 · Frontiers in Immunology
Colorectal cancer: the immune microenvironment and the gut microbiota – new perspectives, challenges, and opportunities
Ping Zhou, Wangzheqi Zhang, Yan Liao, Zhiyong Zhai, Sicun Lu, Shuya Jiang, Wei Hu, Wei Gong · 2025 · International Journal of Surgery
Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
Botao Wang, Lei Yang, Tianyu Liu, Jing Xun, Yuzhen Zhuo, Lanqiu Zhang, Qi Zhang, Ximo Wang · 2021 · Frontiers in Pharmacology
Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
Rui Chen, Wantao Wu, Tao Liu, Yihan Zhao, Yifan Wang, Hao Zhang, Zeyu Wang, Ziyu Dai, Xiaoxi Zhou, Peng Luo et al. · 2022 · Frontiers in Immunology
A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation
Fengtian Li, Yi Zhou, Xinyue Lin, Yaxin Zhang, Qingyong Hu, Enen Zhao, H.‐B. Li, Xingyan Pan, Feng Shu, Kun Zhang et al. · 2025 · Journal of Translational Medicine
Review: KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer
Colin William Steele, Thomas Whittle, Jesse Joshua Smith · 2019 · Chinese Clinical Oncology
Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway
Fangzhi Lou, Huiqing Long, Shihong Luo, Yiyun Liu, Juncai Pu, Haiyang Wang, Ping Ji, Xin Jin · 2022 · Experimental Neurology
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
Jung Ho Kim, Jiyun Hong, Ji Ae Lee, Minsun Jung, Eunwoo Choi, Nam‐Yun Cho, Gyeong Hoon Kang, Sangwoo Kim · 2024 · Cancer Immunology Immunotherapy
Deciphering of intra‐tumoural heterogeneity and the interplay between metastasis‐associated meta‐program and myofibroblasts in gastric cancer
Xiongyan Wu, Zhijian Jin, Baolong Li, Yifan Lu, Junyi Hou, Lizhong Yao, Zhenjia Yu, Qingqing Sang, Beiqin Yu, Jianfang Li et al. · 2025 · Clinical and Translational Medicine
Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice
Rocío Olivera-Salazar, Mariano García‐Arranz, Aranzazu Sánchez, Susana Olmedillas López, Luz Vega-Clemente, Luis Javier Serrano, Blanca M. Herrera, Damián García‐Olmo · 2022 · Scientific Reports
Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer
Benny Johnson · 2023 · Cancers
Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models
Lucas A. Horn, Hanne Lind, Kristen Fousek, Haiyan Qin, Nika Rajabian, Shantel M. Angstadt, Nicole Hsiao-Sanchez, Miriam Marlene Medina-Enríquez, Marcus D. Kelly, Clint Tanner Allen et al. · 2024 · Journal of Experimental & Clinical Cancer Research
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
Yanjie Chen, Shu-Neng Luo, Hao Wu, Ning‐Ping Zhang, Ling Dong, Taotao Liu, Li Liang, Xizhong Shen · 2022 · Journal of Translational Medicine
Revealing the contribution of somatic gene mutations to shaping tumor immune microenvironment
Liwen Xu, Shiwei Zhu, Yujia Lan, Min Yan, Zedong Jiang, Jiali Zhu, Gaoming Liao, Yanyan Ping, Jinyuan Xu, Bo Pang et al. · 2022 · Briefings in Bioinformatics
Costimulatory molecule‐ related lncRNA model as a potential prognostic biomarker in non‐small cell lung cancer
Yuanshan Yao, Fuzhi Yang, Anna M. Chen, Qingwang Hua, Wen Gao · 2022 · Cancer Medicine
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
Yupeng Jiang, Yuyao Liu, Hong Huang, Tiantian Zhao, Zengyi Zhao, Yawen Gao · 2025 · Cancer Immunology Immunotherapy
KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner
Pierre-Antoine Laurent, Marina Milić, Clément Quevrin, Lydia Meziani, Winchygn Liu, Daphné Morel, Nicolas Signolle, Céline Clémenson, Antonin Lévy, Michele Mondini et al. · 2023 · Journal of Translational Medicine
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study
Rosana Carvalho Silva, Paolo G. V. Martini, Christa Hohoff, Stefania Mattevi, Marco Bortolomasi, Maria Abate, Valentina Menesello, Massimo Gennarelli, Bernhard Theodor Baune, Alessandra Minelli · 2024 · Clinical Epigenetics
Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators
Jianshang Huang, Lei Xiong, Sainan Tang, Junhao Zhao, Li Zuo · 2024 · International Journal of Molecular Sciences
Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy
Jiahui Lin, Zhu Gong, Yen‐Shen Lu, Jiongheng Cai, Junjie Zhang, Jia‐Heng Tan, Zhi‐Shu Huang, Shuobin Chen · 2025 · Molecules
Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment
Hrvoje Mišetić, Mohamed Reda Keddar, Jean‐Pierre Jeannon, Francesca D. Ciccarelli · 2023 · Genome Medicine
Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma
Lisha Ying, Chunliu Zhang, Alexandre Reuben, Yiping Tian, Jiaoyue Jin, Canming Wang, Jing Bai, Xinyuan Liu, Jianfei Fang, Tingting Feng et al. · 2023 · iScience
Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies
Kang Wang, Yun Wang, Kai Yin · 2024 · Journal of Cancer Research and Clinical Oncology
Immunotherapy in Colorectal Cancer — Finding the Achilles’ Heel
Robin Park, Anwaar Saeed · 2024 · NEJM Evidence
Single-Cell Transcriptomics Reveals Cellular Heterogeneity and Drivers in Serrated Pathway-Driven Colorectal Cancer Progression
Jiahui Wang, Yu Long Zhang, Xinyi Chen, Qi Sheng, Junluo Yang, Yuyao Zhu, Yuhang Wang, Fangrong Yan, Jingya Fang · 2024 · International Journal of Molecular Sciences
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, Karkala Sreedhara Ranganath Pai, Mandar Bhonde · 2025 · Biochemical and Biophysical Research Communications
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Shenao Fu, Jiayao Ma, Changjing Cai, Jun Tan, Xiangying Deng, Hong Shen, Shan Zeng, Yihong Chen, Ying Han · 2025 · Journal of Experimental & Clinical Cancer Research
Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
Kaixin Yang, Chengyun Li, Yang Liu, Xueyan Gu, Longchang Jiang, Lei Shi · 2022 · Cells
Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
Mengke Fan, Guochuan Zhang, Mingfang Xie, Xinbo Liu, Qi Zhang, Ling Wang · 2022 · Current Oncology
Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes
Laverne D. Robilliard, Jane J. Yu, Akshata Anchan, Graeme J. Finlay, Catherine Elizabeth Angel, E. Scott Graham · 2022 · International Journal of Molecular Sciences
Regularized survival learning and cross-database analysis enabled identification of colorectal cancer prognosis-related immune genes
Dongmei Ai, Mingmei Wang, Qingchuan Zhang, Longwei Cheng, Yishu Wang, Xiuqin Liu, Li C. Xia · 2023 · Frontiers in Genetics
Cholangiocarcinoma Risk Factors Open the Floodgates for Gut Microbes and Immunosuppressive Myeloid Cells
Sharmeen Chagani, Lawrence N. Kwong · 2021 · Cancer Discovery
Unveiling the dual role of circulating tumor cells in colorectal cancer immunotherapy: a comprehensive review of biomarker utility and immune microenvironment crosstalk
Yifan Feng, Gang Liu, Qixue Cai, Jianping Zhou · 2025 · Frontiers in Immunology
Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancer
Elisa Sorrenti, Valeria Governa, Davide Bressan, Eleonora Cremonesi, Nicolò Formaggio, Irene Latino, Bianca Calì, Cristina Torcasio, Camilla Basso, Jacopo Galafassi et al. · 2026 · Cell Host & Microbe
Tumor heterogeneity: development, mechanisms, and therapeutic implications
Jianhong Zhang, Heng Li, Shuo Ru, Hui Feng, Guo J, Danlei Sun, Tingxiu Xiang, Daqian Xu, Yang Luo · 2026 · Signal Transduction and Targeted Therapy
Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance
Louis Boafo Kwantwi · 2023 · Clinical and Experimental Medicine
Patterns of immune infiltration in lung adenocarcinoma revealed a prognosis-associated microRNA–mast cells network
Chunlin Wang, Xi Tang, Jiaojian Wang, Yanhua Xu · 2019 · Human Cell
The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
Xuefei Liu, Ziwei Luo, Xuechen Ren, Zhihang Chen, Xiaoqiong Bao, Jianghua Zheng, Zhixiang Zuo · 2022 · Frontiers in Cell and Developmental Biology
Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity
Saleh Almasabi, Richard L. Boyd, Afsar U. Ahmed, Bryan R.G. Williams · 2022 · Frontiers in Oncology
MYC promotes immune-suppression in TNBC via inhibition of IFN signaling
Dario Zimmerli, Chiara Svetlana Brambillasca, Francien Talens, Jinhyuk Bhin, Arkajyoti Bhattacharya, Stacey E. P. Joosten, Ana Moises Da Silva, Max D. Wellenstein, Kelly Kersten, Mart de Boo et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Impact and potential value of immunosenescence on solid gastrointestinal tumors
Tianshuai Zhang, Rongbo Wen, Hao Fan, Yue Yu, Hang Jia, Zhiying Peng, Leqi Zhou, Guanyu Yu, Wei Zhang · 2024 · Frontiers in Immunology
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
Ganghui Ye · 2024 · American Journal of Cancer Research
A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors
Alexandre Bertucci, Dr Taleb Khaoula -, Emilien Billon, Téo Fernez, Philippe Rochigneux · 2026 · Frontiers in Immunology
Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI
Chiara Cataldi, Beliz Bahar Karaoğlan, Elena Liotta, Sara De Dosso · 2026 · Cancers
Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation
Paige E. Solomon, Lisa L. Kirkemo, Gary M. Wilson, Kevin Leung, Mark H. Almond, Leanne C. Sayles, Alejandro Sweet-Cordero, Oren S. Rosenberg, Joshua J. Coon, James A. Wells · 2022 · Molecular & Cellular Proteomics
The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer
Desirée Martín‐García, Teresa Téllez, Maximino Redondo, Marilina García‐Aranda · 2023 · Current Medicinal Chemistry
KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down‐regulating SERTAD4
Yizhen Chen, Yuanyuan Zheng, Shaolin Liu · 2024 · Journal of Cellular and Molecular Medicine
Krill Oil Perturbs Proliferation and Migration of Mouse Colon Cancer Cells in vitro by Impeding Extracellular Signal‐Regulated Protein Kinase Signaling Pathway
Weiqiang Jing, Yuxuan Bi, Ganyu Wang, Shuyan Zeng, Lihui Han, Hui Yang, Na Wang, Yunxue Zhao · 2020 · Lipids
Remarkable Response of EGFR- and HER2-Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review
Hong‐Shuai Li, Lili Yang, Mingyi Zhang, Ke Cheng, Ye Chen, Jiyan Liu · 2020 · Frontiers in Oncology
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Abolarinwa Bilikis Aderonke, Ridwan Babatunde Ibrahim, Yen‐Hua Huang · 2019 · International Journal of Molecular Sciences
lncRNA GAU1 Induces GALNT8 Overexpression and Potentiates Colorectal Cancer Progression
Xuemei Tang, Haoyu Ruan, Liu Dong, Sihan Li, Zhiyuan Wu, Ming Guan · 2021 · Gastroenterology Research and Practice